SCNX

Scienture Holdings, Inc. Common Stock
Data: 2026-01-30
$0.4543
Price
-5.51%
Change
$4.1
52W High
$0.453
52W Low

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Quick Stats
Jan 30, 2026

45.6

AI Score

HOLD

0.44

Volume Ratio

Next Earnings

15

+ve Days (30d)

14

-ve Days (30d)

SCNX Stock Summary

Last updated Jan 30, 2026

SCNX is currently trading at $0.4543, positioned below its 200-day moving average of $0.98, suggesting bearish momentum. The stock has a 52-week range of $0.453 to $4.1.

Technical Analysis: The 50-day moving average stands at $0.55, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 29.659, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.313, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates SCNX at 45.6/100 with a HOLD recommendation.

SCNX (Scienture Holdings, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 29.659
CMF (20) -0.313
ROC (10) -13.086
ADX (14) 9.004
Indicator Value
MACD (12,26,9) -0.028
AROONOSC (14) -78.571
WILLAMS %R (14) -99.124
MFI (14) 75.983
SCNX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

SCNX Price vs Max Options Open Interest
SCNX Max Change In Options Open Interest

SCNX Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SCNX Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SCNX Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SCNX Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Scienture Holdings, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

SCNX Moving Averages Analysis

SCNX (Scienture Holdings, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 0.5
20 0.52
30 0.52
50 0.55
100 0.69
200 0.98

SCNX Fundamental Analysis

P/E (Forward) 21.8341
P/E (Trailing) 0.6628
Market Cap ($) 20.2 million
Earnings/Share ($) 0.75
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) 0
EPS Estimate Next Year ($) 0
WallStreet Target Price ($) --
Most Recent Quarter